Hi to all members of the HealingWell Alzheimer's discussion forum. You may be interested in the ICARA/Bapineuzumab (Bapi) study if you or someone you know has been diagnosed with probable Alzheimer's disease.
The ICARA (Bapi) study is currently enrolling patients in a clinical study evaluating the safety and effectiveness of an investigational drug aimed at slowing down the progression of Alzheimer's. All study-related procedures and medication will be provided at no cost. During the study, each participant will be monitored by a medical team, including a nurse or study coordinator, and a physician. Positive results from the ICARA (Bapi) study could lead to a change in doctors' approach to the treatment of Alzheimer's disease and could possibly result in Bapi being made available to a broader range of Alzheimer's patients.
Post Edited By Moderator (Red_34) : 2/3/2009 10:46:40 AM (GMT-7)